4-5628743-TAA-TAAA

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2

The NM_147127.5(EVC2):​c.1711-10dupT variant causes a intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.012 ( 32 hom., cov: 0)
Exomes 𝑓: 0.013 ( 12 hom. )

Consequence

EVC2
NM_147127.5 intron

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.151

Publications

4 publications found
Variant links:
Genes affected
EVC2 (HGNC:19747): (EvC ciliary complex subunit 2) This gene encodes a protein that functions in bone formation and skeletal development. Mutations in this gene, as well as in a neighboring gene that lies in a head-to-head configuration, cause Ellis-van Creveld syndrome, an autosomal recessive skeletal dysplasia that is also known as chondroectodermal dysplasia. Mutations in this gene also cause acrofacial dysostosis Weyers type, also referred to as Curry-Hall syndrome, a disease that combines limb and facial abnormalities. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
EVC2 Gene-Disease associations (from GenCC):
  • acrofacial dysostosis, Weyers type
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • Ellis-van Creveld syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Myriad Women’s Health, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 4-5628743-T-TA is Benign according to our data. Variant chr4-5628743-T-TA is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 1168233.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0123 (1828/148734) while in subpopulation AFR AF = 0.0399 (1634/40936). AF 95% confidence interval is 0.0383. There are 32 homozygotes in GnomAd4. There are 872 alleles in the male GnomAd4 subpopulation. Median coverage is 0. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 32 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EVC2NM_147127.5 linkc.1711-10dupT intron_variant Intron 11 of 21 ENST00000344408.10 NP_667338.3 Q86UK5-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EVC2ENST00000344408.10 linkc.1711-10dupT intron_variant Intron 11 of 21 1 NM_147127.5 ENSP00000342144.5 Q86UK5-1
EVC2ENST00000310917.6 linkc.1471-10dupT intron_variant Intron 11 of 21 1 ENSP00000311683.2 Q86UK5-2
EVC2ENST00000475313.5 linkn.1471-10dupT intron_variant Intron 11 of 22 1 ENSP00000431981.1 A0A0C4DGE7
EVC2ENST00000509670.1 linkn.*104-10dupT intron_variant Intron 12 of 22 1 ENSP00000423876.1 E9PFT2

Frequencies

GnomAD3 genomes
AF:
0.0123
AC:
1827
AN:
148626
Hom.:
32
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.0400
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00581
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0109
Gnomad FIN
AF:
0.000618
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000330
Gnomad OTH
AF:
0.0143
GnomAD2 exomes
AF:
0.0108
AC:
2028
AN:
187796
AF XY:
0.0104
show subpopulations
Gnomad AFR exome
AF:
0.0492
Gnomad AMR exome
AF:
0.00691
Gnomad ASJ exome
AF:
0.00553
Gnomad EAS exome
AF:
0.00125
Gnomad FIN exome
AF:
0.00796
Gnomad NFE exome
AF:
0.00455
Gnomad OTH exome
AF:
0.0102
GnomAD4 exome
AF:
0.0126
AC:
14991
AN:
1193360
Hom.:
12
Cov.:
0
AF XY:
0.0124
AC XY:
7324
AN XY:
592584
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0540
AC:
1676
AN:
31030
American (AMR)
AF:
0.00758
AC:
290
AN:
38272
Ashkenazi Jewish (ASJ)
AF:
0.0103
AC:
211
AN:
20526
East Asian (EAS)
AF:
0.00225
AC:
79
AN:
35086
South Asian (SAS)
AF:
0.0216
AC:
1481
AN:
68674
European-Finnish (FIN)
AF:
0.00943
AC:
412
AN:
43706
Middle Eastern (MID)
AF:
0.0133
AC:
64
AN:
4802
European-Non Finnish (NFE)
AF:
0.0112
AC:
10104
AN:
901848
Other (OTH)
AF:
0.0136
AC:
674
AN:
49416
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.279
Heterozygous variant carriers
0
1936
3872
5807
7743
9679
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
458
916
1374
1832
2290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0123
AC:
1828
AN:
148734
Hom.:
32
Cov.:
0
AF XY:
0.0120
AC XY:
872
AN XY:
72486
show subpopulations
African (AFR)
AF:
0.0399
AC:
1634
AN:
40936
American (AMR)
AF:
0.00581
AC:
87
AN:
14986
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3412
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5096
South Asian (SAS)
AF:
0.0107
AC:
50
AN:
4654
European-Finnish (FIN)
AF:
0.000618
AC:
6
AN:
9716
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000330
AC:
22
AN:
66702
Other (OTH)
AF:
0.0141
AC:
29
AN:
2050
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
85
170
256
341
426
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0272
Hom.:
399

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Ellis-van Creveld syndrome;C0457013:Curry-Hall syndrome Benign:2
Dec 23, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Aug 20, 2019
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.15
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35103377; hg19: chr4-5630470; COSMIC: COSV60405755; API